Plasmodium falciparum-specific human T cell clones: evidence for helper and cytotoxic activities.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 3030767)

Published in Eur J Immunol on February 01, 1987

Authors

F Sinigaglia, H Matile, J R Pink

Articles by these authors

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med (2001) 5.56

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol (1999) 5.13

Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med (1997) 3.57

Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell (1993) 3.41

Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol (1991) 3.40

A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature (1989) 3.33

Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol (1998) 2.84

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest (1998) 2.78

Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71

Structural studies of immunoglobulin G. Nature (1969) 2.63

The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol (1998) 2.32

Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature (1995) 2.30

Human immunoglobulin subclasses. Partial amino acid sequence of the constant region of a gamma 4 chain. Biochem J (1970) 2.11

Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest (2001) 2.10

The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest (2001) 2.05

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med (1995) 2.02

Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature (1992) 1.98

Structure and evolution of immunoglobulins. Prog Biophys Mol Biol (1970) 1.96

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest (1997) 1.94

An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol (1998) 1.90

Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol (1987) 1.89

Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med (1994) 1.81

Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med (1992) 1.78

High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc Natl Acad Sci U S A (1994) 1.69

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med (1995) 1.67

The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65

4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1996) 1.65

Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun (1991) 1.60

Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J Immunol (1985) 1.59

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med (1999) 1.58

A naturally occurring gene encoding the major surface antigen precursor p190 of Plasmodium falciparum lacks tripeptide repeats. EMBO J (1987) 1.58

Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51

Selection of T cell epitopes and vaccine engineering. Methods Enzymol (1991) 1.50

Use of prior vaccinations for the development of new vaccines. Science (1990) 1.48

Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect Immun (1992) 1.45

The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42

A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J Immunol (1990) 1.35

Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3. Mol Biochem Parasitol (1997) 1.34

Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med (2001) 1.32

Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes. J Immunol (1988) 1.31

Rearrangement of chicken immunoglobulin genes is not an ongoing process in the embryonic bursa of Fabricius. Proc Natl Acad Sci U S A (1986) 1.29

Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J Immunol (1988) 1.28

Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol (1998) 1.28

Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med (1995) 1.28

In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur J Immunol (1993) 1.24

A common mechanism for blockade of heme polymerization by antimalarial quinolines. J Biol Chem (1998) 1.23

Characterisation and sequence of a protective rhoptry antigen from Plasmodium falciparum. Mol Biochem Parasitol (1990) 1.22

Localization of Th-cell subsets in inflammation: differential thresholds for extravasation of Th1 and Th2 cells. Immunol Today (2000) 1.21

The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trials. Mol Biochem Parasitol (1989) 1.20

Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J (2004) 1.20

Inter heavy-light chain disulphide bridge in immune globulins. Nature (1967) 1.20

Expression and characterisation of plasmepsin I from Plasmodium falciparum. Eur J Biochem (1997) 1.19

Epitopes recognized by human T cells map within the conserved part of the GP190 of P. falciparum. Science (1988) 1.19

A variable region subclass of heavy chains common to immunoglobulins G, A, and M and characterized by an unblocked amino-terminal residue. Proc Natl Acad Sci U S A (1970) 1.19

A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro. Biochem Pharmacol (1998) 1.19

Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates. EMBO J (1988) 1.17

Aldolase activity of a Plasmodium falciparum protein with protective properties. Science (1988) 1.17

Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol (1997) 1.16

T-lymphocyte differentiation is accompanied by increase in sialic acid content of Thy-1 antigen. Nature (1980) 1.16

HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate. Int Immunol (1991) 1.16

Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15

[New aspects of the part of the vector played by Ixodes ricinus L. in Switzerland. Preliminary note (author's transl)]. Acta Trop (1979) 1.15

Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. J Immunol (1997) 1.13

Diversity of antibodies to cross-reacting nitrophenyl haptens in inbred mice. Eur J Immunol (1974) 1.12

European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies. Arch Virol (1985) 1.10

Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells. J Exp Med (2000) 1.09

CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J Immunol (1993) 1.09

Counting components of the chicken's B cell system. Immunol Rev (1986) 1.09

Variability of interchain binding of immunoglobulins. Interchain bridges of mouse IgG2a and IgG2b. Nature (1970) 1.09

Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein. Eur J Immunol (1988) 1.09

Nomenclature for chicken major histocompatibility (B) complex. Immunogenetics (1982) 1.08

Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation. J Virol (1999) 1.07

Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores. Antimicrob Agents Chemother (2000) 1.07

Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells. Eur J Immunol (2000) 1.05

Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J Med Chem (1999) 1.05

Studies of an unusual biclonal gammopathy: implications with regard to genetic control of normal immunoglobulin synthesis. Ann N Y Acad Sci (1971) 1.05

Biology of the chicken MHC (B complex). Crit Rev Immunol (1992) 1.03

Selective interaction of Ni with an MHC-bound peptide. EMBO J (1991) 1.03

HLA class II peptide binding specificity and autoimmunity. Adv Immunol (1997) 1.02

New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein. Eur J Immunol (1990) 1.02

Analysis of the permissive association of a malaria T cell epitope with DR molecules. J Immunol (1991) 1.01

Platelet activation by von Willebrand factor requires coordinated signaling through thromboxane A2 and Fc gamma IIA receptor. J Biol Chem (2001) 1.00

Pathogenesis and immunotherapy of autoimmune diseases. Immunol Today (1997) 1.00

Avian B cell precursors: surface immunoglobulin expression is an early, possibly bursa-independent event. Eur J Immunol (1986) 0.99

C-reactive protein protects against preerythrocytic stages of malaria. Infect Immun (1989) 0.99

Upregulation of integrin alpha6/beta1 and chemokine receptor CCR1 by interleukin-12 promotes the migration of human type 1 helper T cells. Blood (1999) 0.99

Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility. Oncogene (2007) 0.98

A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1. Mol Biochem Parasitol (1991) 0.97